Actionable insights straight to your inbox

Equities logo

New York Allows Medical Marijuana for Chronic Pain

Chronic pain has been shown to be meaningfully aided by cannabis.
David N. Feldman is a partner at Duane Morris LLP, where he concentrates his practice on corporate and securities law and mergers and acquisitions, as well as general representation of public and private companies, entrepreneurs, investors, and private equity and venture capital firms. Mr. Feldman also advises small businesses with regard to alternatives to traditional financing through initial public offerings. His popular blog at www.DavidFeldmanBlog.com, focusing on entrepreneurship and the regulatory environment, has been recognized by LexisNexis as a Top 25 corporate law blog, and his videos appear on his YouTube channel, The Entrepreneur’s Advocate. Mr. Feldman is a 1985 graduate of the University of Pennsylvania Law School, where he was managing editor of the student newspaper, the Penn Law Forum, and a graduate of the Wharton School of the University of Pennsylvania. He has served as chair of the board of Wharton’s global alumni association.
David N. Feldman is a partner at Duane Morris LLP, where he concentrates his practice on corporate and securities law and mergers and acquisitions, as well as general representation of public and private companies, entrepreneurs, investors, and private equity and venture capital firms. Mr. Feldman also advises small businesses with regard to alternatives to traditional financing through initial public offerings. His popular blog at www.DavidFeldmanBlog.com, focusing on entrepreneurship and the regulatory environment, has been recognized by LexisNexis as a Top 25 corporate law blog, and his videos appear on his YouTube channel, The Entrepreneur’s Advocate. Mr. Feldman is a 1985 graduate of the University of Pennsylvania Law School, where he was managing editor of the student newspaper, the Penn Law Forum, and a graduate of the Wharton School of the University of Pennsylvania. He has served as chair of the board of Wharton’s global alumni association.

In a major development for New York, its Department of Health officially approved a regulation, first proposed in December, to allow people with “any severe debilitating pain that the practitioner determines degrades health and functional capability” that has lasted or is expected to last at least three months to access legal medical marijuana. The state separately also approved allowing physician’s assistants to prescribe medical cannabis under certain conditions.

New York State started with one of the smallest lists of ailments that can be treated with medical cannabis, taking a very limited approach at first. So this is a very positive step, though observers are hoping things like PTSD also would be added, as New Jersey recently did. New York also looked at Alzheimer’s, muscular dystrophy, dystonia, and rheumatoid arthritis but has not decided to add them yet.

One of the few maladies that has actually been researched, chronic pain has been shown to be meaningfully aided by cannabis and a much safer option than opioids, which are often addictive. Now what we need: more research! A lot is going on in Canada, Israel and other places, but hopefully the DEA will continue to ease restrictions on research here in the US.

A weekly five-point roundup of critical events in fintech, the future of finance and the next wave of banking industry transformation.